Overall, although the results obtained here in vitro on a cell culture line need to be validated in vivo on animal models, the present study shows the potential therapeutic value of peptides corresponding to the region of the sequence of PrPC involved in self-recognition, or other molecules potentially mimicking the same sequence trait, for the treatment of AD. This evidence concerns the gene PRNP and Alzheimer disease.